Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease: A New Immunoregulatory Pathway-Reference-Cited by-同舟云学术

Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease: A New Immunoregulatory Pathway

Published:2008-09 Issue:3 Volume:135 Page:871-881.e5
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Haile Lydia A.,von Wasielewski Reinhard,Gamrekelashvili Jaba,Krüger Christine,Bachmann Oliver,Westendorf Astrid M.,Buer Jan,Liblau Roland,Manns Michael P.,Korangy Firouzeh,Greten Tim F.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference40 articles.

1. Unravelling the pathogenesis of inflammatory bowel disease;Xavier;Nature,2007

2. Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease;Wirtz;Int J Colorectal Dis,2000

3. Inflammatory bowel disease: cause and immunobiology;Baumgart;Lancet,2007

4. The immunological and genetic basis of inflammatory bowel disease;Bouma;Nat Rev Immunol,2003

5. In IBD eight can come before four;Cheroutre;Gastroenterology,2006

Cited by 264 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early administration of Wumei Wan inhibit myeloid-derived suppressor cells via PI3K/Akt pathway and amino acids metabolism to prevent colitis-associated colorectal cancer;Journal of Ethnopharmacology;2024-10

2. DJ-X-013 reduces LPS-induced inflammation, modulates Th17/ myeloid-derived suppressor cells, and alters NF-κB expression to ameliorate experimental colitis;Biomedicine & Pharmacotherapy;2024-10

3. Exploring the immunometabolic potential of Danggui Buxue Decoction for the treatment of IBD-related colorectal cancer;Chinese Medicine;2024-08-29

4. Shifting phenotype and differentiation of CD11b+Gr.1+ immature heterogeneous myeloid derived adjuster cells support inflammation and induce regulators of IL17A in imiquimod induced psoriasis;Inflammation Research;2024-07-25

5. Protective effect of Cyclo(His‐Pro) on peritoneal fibrosis through regulation of HDAC3 expression;The FASEB Journal;2024-07-10